New hope for tough lymphomas? experimental drug brincidofovir enters global trial
Disease control
Terminated
This study tests an experimental drug called brincidofovir given through a vein for people with lymphoma that has returned or not responded to prior therapy. The trial has two parts: first, finding the safest dose in up to 18 participants with various lymphomas, then testing that…
Phase: PHASE1, PHASE2 • Sponsor: SymBio Pharmaceuticals • Aim: Disease control
Last updated May 18, 2026 12:02 UTC